Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model.
Kashima S, Maeda T, Masuda K, Nagano S, Inoue T, Takeda M, Kono Y, Kobayashi T, Saito S, Higuchi T, Ichise H, Kobayashi Y, Iwaisako K, Terada K, Agata Y, Numakura K, Saito M, Narita S, Yasukawa M, Ogawa O, Habuchi T, Kawamoto H.
Kashima S, et al.
iScience. 2020 Apr 24;23(4):100998. doi: 10.1016/j.isci.2020.100998. Epub 2020 Apr 6.
iScience. 2020.
PMID: 32259478
Free PMC article.